Cliff Asness's NVS Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 281,210 shares of Novartis AG (NVS) worth $44.07 M, representing 0.02% of the portfolio. First purchased in 2024-Q1, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in NVS, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 62,447 shares. Largest reduction occurred in Q4 2024, reducing 5,476 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Novartis (NVS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Novartis (NVS) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +47,339 | Add 20.24% | 281,210 | $156.72 |
| Q1 2026 | +47,271 | Add 25.33% | 233,871 | $152.75 |
| Q4 2025 | +50,641 | Add 37.25% | 186,600 | $137.87 |
| Q3 2025 | +62,447 | Add 84.95% | 135,959 | $128.24 |
| Q2 2025 | +50,939 | Add 225.66% | 73,512 | $121.01 |
| Q1 2025 | +11,444 | Add 102.83% | 22,573 | $111.48 |
| Q4 2024 | -5,476 | Reduce 32.98% | 11,129 | $97.31 |
| Q3 2024 | +6,903 | Add 71.15% | 16,605 | $115.02 |
| Q2 2024 | +6,990 | Add 257.74% | 9,702 | $106.46 |
| Q1 2024 | +2,712 | New Buy | 2,712 | $96.73 |
Cliff Asness's Novartis Investment FAQs
Cliff Asness first purchased Novartis AG (NVS) in Q1 2024, acquiring 2,712 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Novartis AG (NVS) for 10 quarters since Q1 2024.
Cliff Asness's largest addition to Novartis AG (NVS) was in Q3 2025, adding 135,959 shares worth $17.44 M.
According to the latest 13F filing for Q2 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 281,210 shares of Novartis AG (NVS), valued at approximately $44.07 M.
As of the Q2 2026 filing, Novartis AG (NVS) represents approximately 0.02% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Novartis AG (NVS) was 281,210 shares, as reported at the end of Q2 2026.